Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Iridium(III)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent

US Patent 9840526 · Granted Dec 12, 2017

Assignee

Inventors

View full patent text on Google Patents →